![Gordon C. Brandt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gordon C. Brandt
Directeur Technique/Scientifique/R&D chez Profil Institute for Clinical Research, Inc.
Postes actifs de Gordon C. Brandt
Sociétés | Poste | Début | Fin |
---|---|---|---|
Profil Institute for Clinical Research, Inc.
![]() Profil Institute for Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Profil Institute for Clinical Research, Inc. operates as a full-service clinical research organization (CRO), that focuses on diabetes, obesity and NAFLD/NASH. It offers clinical development, regulatory affair, clinical research, scientific, data management and statistical, monitoring, quality and compliance, and recruitment services. The company was founded in 2004 and is headquartered in Chula Vista, CA. | Directeur Technique/Scientifique/R&D | - | - |
Conseiller Juridique Général | - | - |
Historique de carrière de Gordon C. Brandt
Anciens postes connus de Gordon C. Brandt
Sociétés | Poste | Début | Fin |
---|---|---|---|
PHASERX, INC. | Directeur Technique/Scientifique/R&D | 20/07/2016 | 01/10/2017 |
MDRNA, Inc.
![]() MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | President | 01/11/2002 | 30/09/2008 |
Sonus Pharmaceuticals, Inc.
![]() Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | Corporate Officer/Principal | - | - |
Formation de Gordon C. Brandt
Yale University | Undergraduate Degree |
The University of California, San Francisco | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
President | 1 |
Undergraduate Degree | 1 |
Sectorielle
Commercial Services | 3 |
Consumer Services | 3 |
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
PHASERX, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
MDRNA, Inc.
![]() MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
Profil Institute for Clinical Research, Inc.
![]() Profil Institute for Clinical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Profil Institute for Clinical Research, Inc. operates as a full-service clinical research organization (CRO), that focuses on diabetes, obesity and NAFLD/NASH. It offers clinical development, regulatory affair, clinical research, scientific, data management and statistical, monitoring, quality and compliance, and recruitment services. The company was founded in 2004 and is headquartered in Chula Vista, CA. | Commercial Services |
Sonus Pharmaceuticals, Inc.
![]() Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | Health Technology |
- Bourse
- Insiders
- Gordon C. Brandt
- Expérience